ReviewBiomedical journal2026
Artificial intelligence in infection surveillance: Data integration, applications and future directions.
Review in Biomedical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Revisiting Animal Reservoirs of Hantavirus and Other Zoonotic Viruses Associated with Cruise Travel: Impact and Prevention.Animals : an open access journal from MDPI · 2026Review
- Review
- Artificial intelligence at the frontlines: Emerging infectious and parasitic diseases in the digital era.New microbes and new infections · 2026Article
- Machine Learning-Based Severity Stratification for Smart Preventive Decision Support: Evidence from Measles Surveillance in a Resource-Constrained Region.Journal of clinical medicine · 2026Article
- The Odyssey of macrophages.Biomedical journal · 2026Article
- Artificial intelligence is transforming disease surveillance, but governance is failing to keep pace.Frontiers in digital health · 2026Article
- Childhood obesity in changing food systems: mediterranean diet, socioeconomic inequalities and AI-driven personalized nutrition - the case of Italy.Frontiers in public health · 2026Review
- Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This narrative review explores the transformative potential of Artificial Intelligence (AI) in addressing the limitations of traditional infection surveillance methods, which are often hindered by slow response times and restricted analytical capabilities. By integrating diverse data sources such as electronic health records, social media, spatiotemporal data, and wearable technologies, AI enables earlier detection of outbreaks, real-time monitoring, and improved disease transmission prediction. We reviewed peer-reviewed articles and reports to analyze AI's capacity to process heterogeneous datasets using machine learning. Specific applications, such as the use of social media for outbreak prediction, wearable sensors for early infection detection, and spatiotemporal data for tracking disease spread, were synthesized. AI-driven infection surveillance models improve the prediction of outbreaks and estimation of disease incidence. They also enhance risk assessment by identifying highly susceptible individuals and geographic hotspots, thereby strengthening public health strategies. For instance, integrating social media data improves influenza forecasting accuracy, while wearable technologies enable real-time monitoring of infection dynamics. However, these advancements face challenges such as data privacy concerns, model validation, and the need for external testing across diverse epidemiological settings. Despite these challenges, AI holds significant promise for revolutionizing infection surveillance. Future efforts should prioritize refining AI models to improve adaptability, ensuring robust validation processes, and developing integrative tools that merge diverse data sources for effective public health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.